In a previous post about health insurance fraud we wrote, “These fraudulent activities take a wide variety of forms, bearing witness to the inventiveness of those bent on health insurance fraud.” https://www.videntpartners.com/blog/2024/many-faces-health-insurance-fraud. The fraudulent scheme in today’s case, U.S. v. Julian Omidi (9th Cir. 1/16/2025), bears witness to that inventiveness.
A number of cosmetic (makeup) products – such as blush, eyeshadow, foundation, and liquid makeup – contain talc. In recent years, every major cosmetics manufacturer has been sued for alleged contamination of talc-containing products with asbestos. The plaintiffs assert that they have a well-founded fear that they will develop mesothelioma (which is caused only by inhalation of asbestos fibers) years from now and will require regular testing into the indefinite future.
Real estate agents can be held liable under several legal theories, reflecting the complex nature of their professional responsibilities.
Negligence is one of the most common grounds for lawsuits against real estate agents. This occurs when an agent fails to exercise reasonable care in performing their duties. Examples of negligence include:
Medical directors play a crucial role at health insurance companies, serving as the bridge between the medical and insurance worlds. Their responsibilities are diverse and essential for ensuring accurate, fair, and efficient handling of medical claims and policies.
Fifteen-year-old Nathan Bruno, a student at Portsmouth (Rhode Island) High School, committed suicide on February 7, 2018. The Portsmouth School Committee commissioned an independent investigation by an attorney, whose report was released in June 2019. A newspaper article provides an excellent, detailed summary of the 63-page report. I recommend it to any reader wants a clear picture of the chain of events that led to Na
Genetic testing and genetic screening are related but distinct approaches to identifying genetic variations and potential health risks.
Genetic testing is focused on individuals. It is used to diagnose specific conditions in people who show symptoms; to confirm or rule out suspected genetic disorders; to determine an individual’s risk of develop certain diseases; and to identify carriers of genetic mutations the could be passed to offspring. It is targeted, examining specific genes or sets of genes in detail.
We recently posted a general overview of failure to warn cases, https://www.videntpartners.com/blog/2024/product-liability-%E2%80%93-failure-warn. That post concluded as follows: “These cases often involve complex medical and scientific concepts, so working with experienced experts is essential. Vident Partners has safety experts (which includes failure to warn) in a wide variety of fields.”
Vident Partners is almost at its 20th anniversary, having begun its long run in the expert referral business as Healthcare Litigation Support (HLS) in 2005.
A failure to warn case is a type of product liability lawsuit in which the plaintiff claims that a manufacturer, distributor, or seller failed to provide adequate warnings or instructions about the safe use of the product. Failure to warn is a marketing defect, not a product defect.
The Center for Medicare and Medicaid Innovation (CMMI), also known as the CMS Innovation Center, is a division within the Centers for Medicare & Medicaid Services (CMS). Established by the Affordable Care Act in 2010, the CMS Innovation Center's primary mission is to test innovative payment and service delivery models with the goal of reducing costs while preserving or enhancing the quality of care within Medicare, Medicaid, and the Children's Health Insurance Program.
Key Objectives:
